UNLIMITED TURBO BEAR - IPSEN | Market Closed - Euronext Paris 12:30:01 2024-05-31 pm EDT | ||
| 1.035 EUR | -3.72% |
|
| 1 month | -27.05% | ||
| 3 months | -49.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 1.025 | -4.65% |
| 24-05-30 | 1.075 | -3.59% |
| 24-05-29 | 1.115 | -1.76% |
| 24-05-28 | 1.135 | +6.57% |
| 24-05-27 | 1.065 | +10.36% |
Real-time Euronext Paris
Last update May 31, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 74U2S | |
| ISIN | DE000SQ1HLY9 |
| Date issued | 2022-10-05 |
| Strike | 140.8 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 2.41 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.685 € |
|---|---|
| Lowest since issue | 0.605 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.6
EUR
Average target price
126.4
EUR
Spread / Average Target
+4.81%
- Stock Market
- Certificates
- 74U2S Certificat
